Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Wall Street
Price Targets
Price Targets Summary
Middle East Pharmaceutical Industries Company SJSC
According to Wall Street analysts, the average 1-year price target for Middle East Pharmaceutical Industries Company SJSC is 109.14 SAR with a low forecast of 108.07 SAR and a high forecast of 112.35 SAR.
Revenue
Forecast
Revenue Estimate
Middle East Pharmaceutical Industries Company SJSC
For the last 1 year the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's revenue is 5%. The projected CAGR for the next 4 years is 14%.
Operating Income
Forecast
Operating Income Estimate
Middle East Pharmaceutical Industries Company SJSC
For the last 1 year the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's operating income is -2%. The projected CAGR for the next 4 years is 15%.
Net Income
Forecast
Net Income Estimate
Middle East Pharmaceutical Industries Company SJSC
For the last 1 year the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's net income is -10%. The projected CAGR for the next 4 years is 15%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Middle East Pharmaceutical Industries Company SJSC's stock price target?
Price Target
109.14
SAR
According to Wall Street analysts, the average 1-year price target for Middle East Pharmaceutical Industries Company SJSC is 109.14 SAR with a low forecast of 108.07 SAR and a high forecast of 112.35 SAR.
What is Middle East Pharmaceutical Industries Company SJSC's Revenue forecast?
Projected CAGR
14%
For the last 1 year the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's revenue is 5%. The projected CAGR for the next 4 years is 14%.
What is Middle East Pharmaceutical Industries Company SJSC's Operating Income forecast?
Projected CAGR
15%
For the last 1 year the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's operating income is -2%. The projected CAGR for the next 4 years is 15%.
What is Middle East Pharmaceutical Industries Company SJSC's Net Income forecast?
Projected CAGR
15%
For the last 1 year the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's net income is -10%. The projected CAGR for the next 4 years is 15%.